203 related articles for article (PubMed ID: 32374011)
21. Protective effects of vaccinations and endemic infections on COVID-19: A hypothesis.
Meenakshisundaram R; Senthilkumaran S; Thirumalaikolundusubramanian P
Med Hypotheses; 2020 Oct; 143():109849. PubMed ID: 32480250
[No Abstract] [Full Text] [Related]
22. Vaccine Development Against COVID-19 Prior to Pandemic Outbreaks, Using
Zayed H
Front Immunol; 2020; 11():2051. PubMed ID: 32922408
[No Abstract] [Full Text] [Related]
23. COVID-19 shot protects monkeys.
Cohen J
Science; 2020 May; 368(6490):456-457. PubMed ID: 32355008
[No Abstract] [Full Text] [Related]
24. Sweden's gamble.
Vogel G
Science; 2020 Oct; 370(6513):159-163. PubMed ID: 33033200
[No Abstract] [Full Text] [Related]
25. Progress and Concept for COVID-19 Vaccine Development.
Wu SC
Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
[No Abstract] [Full Text] [Related]
26. BCG-induced trained immunity: can it offer protection against COVID-19?
O'Neill LAJ; Netea MG
Nat Rev Immunol; 2020 Jun; 20(6):335-337. PubMed ID: 32393823
[TBL] [Abstract][Full Text] [Related]
27. Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.
Papachristodoulou E; Kakoullis L; Parperis K; Panos G
Pathog Dis; 2020 Apr; 78(3):. PubMed ID: 32510562
[TBL] [Abstract][Full Text] [Related]
28. Potential alteration of COVID-19 by beta-mercaptoethanol.
Click RE
Future Microbiol; 2020 Sep; 15():1313-1318. PubMed ID: 32951474
[No Abstract] [Full Text] [Related]
29. The COVID-19 pandemic and the use of MS disease-modifying therapies.
Giovannoni G; Hawkes C; Lechner-Scott J; Levy M; Waubant E; Gold J
Mult Scler Relat Disord; 2020 Apr; 39():102073. PubMed ID: 32334820
[No Abstract] [Full Text] [Related]
30. [Not Available].
Nau JY
Rev Med Suisse; 2020 Jun; 16(696):1174-1175. PubMed ID: 32496708
[No Abstract] [Full Text] [Related]
31. Developing Covid-19 Vaccines at Pandemic Speed.
Lurie N; Saville M; Hatchett R; Halton J
N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
[No Abstract] [Full Text] [Related]
32. Covid-19: Human challenge studies will see people purposefully infected with virus.
Mahase E
BMJ; 2020 Oct; 371():m4101. PubMed ID: 33093016
[No Abstract] [Full Text] [Related]
33. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
Heininger U
Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
[No Abstract] [Full Text] [Related]
34. The race for coronavirus vaccines: a graphical guide.
Callaway E
Nature; 2020 Apr; 580(7805):576-577. PubMed ID: 32346146
[No Abstract] [Full Text] [Related]
35. Our choice is not binary between lockdown and herd immunity.
Cheng KK
BMJ; 2020 Oct; 371():m4051. PubMed ID: 33093027
[No Abstract] [Full Text] [Related]
36. Covid-19 and Exercise-Induced Immunomodulation.
Leandro CG; Ferreira E Silva WT; Lima-Silva AE
Neuroimmunomodulation; 2020; 27(1):75-78. PubMed ID: 32506067
[No Abstract] [Full Text] [Related]
37. mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.
Yi C; Yi Y; Li J
Virol Sin; 2020 Jun; 35(3):259-262. PubMed ID: 32524253
[No Abstract] [Full Text] [Related]
38. [Not Available].
Nau JY
Rev Med Suisse; 2020 Aug; 16(703):1526-1527. PubMed ID: 32852178
[No Abstract] [Full Text] [Related]
39. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19.
Neumann-Böhme S; Varghese NE; Sabat I; Barros PP; Brouwer W; van Exel J; Schreyögg J; Stargardt T
Eur J Health Econ; 2020 Sep; 21(7):977-982. PubMed ID: 32591957
[No Abstract] [Full Text] [Related]
40. Keeping track of the SARS-CoV-2 vaccine pipeline.
Parker EPK; Shrotri M; Kampmann B
Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
